稳健医疗
(300888)
| 流通市值：170.79亿 | | | 总市值：171.55亿 |
| 流通股本：5.80亿 | | | 总股本：5.82亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,679,328,547.73 | 10,949,489,967.01 | 7,897,083,664.25 | 5,296,211,956.92 |
| 营业收入 | 2,679,328,547.73 | 10,949,489,967.01 | 7,897,083,664.25 | 5,296,211,956.92 |
| 二、营业总成本 | 2,345,297,815.47 | 9,733,808,334.16 | 6,964,816,025.47 | 4,657,723,411.78 |
| 营业成本 | 1,368,538,882.04 | 5,733,463,029.53 | 4,081,285,917.3 | 2,736,394,780.72 |
| 税金及附加 | 24,985,906.96 | 93,698,779.57 | 67,569,460.52 | 47,206,665.58 |
| 销售费用 | 611,332,276.63 | 2,633,668,842.91 | 1,871,463,933.43 | 1,254,903,652.81 |
| 管理费用 | 214,383,181.15 | 855,447,401.69 | 655,384,247.49 | 436,173,126.72 |
| 研发费用 | 91,133,594.78 | 410,877,566.24 | 291,148,487.39 | 194,377,566.9 |
| 财务费用 | 34,923,973.91 | 6,652,714.22 | -2,036,020.66 | -11,332,380.95 |
| 其中:利息费用 | 12,506,380.19 | 55,114,093.69 | 54,375,575.86 | 32,211,146.81 |
| 其中:利息收入 | 21,062,129.49 | 82,400,032.94 | 61,231,951.15 | 40,152,719.55 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 12,132,519.08 | -24,339,525.82 | -6,829,038.58 | 8,043,719.46 |
| 加:投资收益 | 972,472.41 | 53,091,575.78 | 33,232,651.4 | 10,250,616.45 |
| 资产处置收益 | -736,515.7 | 546,546.56 | -200,723.04 | 1,518,248.05 |
| 资产减值损失(新) | -18,645,697.75 | -251,273,437.71 | -43,758,641.83 | -32,261,264.96 |
| 信用减值损失(新) | 2,850,979.41 | -10,273,088.79 | -17,522,948.91 | -11,497,804.05 |
| 其他收益 | 22,028,266.16 | 84,244,396.64 | 67,601,859.36 | 44,523,302.06 |
| 四、营业利润 | 352,632,755.87 | 1,067,678,099.51 | 964,790,797.18 | 659,065,362.15 |
| 加:营业外收入 | 2,318,960.53 | 8,206,430.16 | 5,429,618.33 | 2,981,866.13 |
| 减:营业外支出 | 6,783,888.69 | 28,063,679.49 | 19,634,505.99 | 16,418,323.58 |
| 五、利润总额 | 348,167,827.71 | 1,047,820,850.18 | 950,585,909.52 | 645,628,904.7 |
| 减:所得税费用 | 77,409,979.74 | 233,703,122.41 | 175,760,669.58 | 127,441,441.9 |
| 六、净利润 | 270,757,847.97 | 814,117,727.77 | 774,825,239.94 | 518,187,462.8 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 270,757,847.97 | 814,117,727.77 | 774,825,239.94 | 518,187,462.8 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 251,490,441.26 | 767,967,461.87 | 731,895,365.61 | 491,998,009.07 |
| 少数股东损益 | 19,267,406.71 | 46,150,265.9 | 42,929,874.33 | 26,189,453.73 |
| 扣除非经常损益后的净利润 | 227,031,917.38 | 705,635,870.36 | 679,110,908.35 | 460,623,731.26 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.43 | 1.32 | 1.26 | 0.84 |
| (二)稀释每股收益 | 0.43 | 1.32 | 1.26 | 0.84 |
| 八、其他综合收益 | -16,596,636.92 | -1,581,626.72 | 4,502,126.6 | 2,654,748.45 |
| 归属于母公司股东的其他综合收益 | -15,819,826.9 | -9,197,211.89 | -1,954,848.76 | -2,122,693.34 |
| 九、综合收益总额 | 254,161,211.05 | 812,536,101.05 | 779,327,366.54 | 520,842,211.25 |
| 归属于母公司股东的综合收益总额 | 235,670,614.36 | 758,770,249.98 | 729,940,516.85 | 489,875,315.73 |
| 归属于少数股东的综合收益总额 | 18,490,596.69 | 53,765,851.07 | 49,386,849.69 | 30,966,895.52 |
| 公告日期 | 2026-04-22 | 2026-04-22 | 2025-10-28 | 2025-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |